Adient Formed a Joint Venture with SCI to Drive Growth in China

Rhea-AI Summary

Adient (NYSE:ADNT) completed acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd. and formed a strategic joint venture on Dec. 8, 2025.

The JV will develop and manufacture automotive seating solutions for the China market with a focus on serving key Chinese OEMs. The partnership combines Adient's global technology with SCI's local insights to accelerate development and mass production, expand market share, and strengthen Adient's local footprint in China.

AI-generated analysis. Not financial advice.

Positive

• Acquired 49% equity stake in SCI (Zhangjiakou) on Dec. 8, 2025
• Joint venture dedicated to development and mass production of seating for China OEMs
• Combines Adient global technology with SCI local insights to accelerate product rollout

Negative

• None.

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Recently, Adient, a global leader in automotive seating, completed the acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd., a local Chinese supplier under Zhejiang Yoening Technology Group, officially establishing a new strategic joint venture. This joint venture will be dedicated to developing and manufacturing innovative and exceptional automotive seating solutions for the rapidly evolving China market, with a particular focus on serving key Chinese OEMs.

This collaboration represents another strategic move for Adient in strengthening its presence in China. Through win-win collaboration, the partnership aims to drive business growth, expand market share, and enhance local footprint to deliver agile service to customers.

The new joint venture will combine Adient's global technology expertise with SCI's local insights to accelerate the development and mass production of innovative seating products. Together, the companies will provide industry-leading automotive seating solutions that cater to both local and global trends for OEMs.

This joint venture marks an important milestone in Adient's continued investment and commitment to the China market. Looking ahead, we will continue to focus on creating value for OEMs and end-users, actively expand our world-class partnerships in China, and grow together with China's automotive industry.

About Adient:
Adient (NYSE: ADNT) is a global leader in automotive seating. With more than 65,000 employees in 29 countries, Adient operates ~200 manufacturing/assembly plants worldwide. We produce and deliver automotive seating for all major OEMs. From complete seating systems to individual components, our expertise spans every step of the automotive seat-making process. We take our products from research and design to engineering and manufacturing — and into millions of vehicles every year.  For more information on Adient, please visit www.adient.com.

View original content:https://www.prnewswire.com/news-releases/adient-formed-a-joint-venture-with-sci-to-drive-growth-in-china-302634743.html

SOURCE Adient

FAQ

What did Adient announce on Dec. 8, 2025 about its China strategy (ADNT)?

Adient acquired a 49% stake in SCI (Zhangjiakou) and formed a joint venture to serve Chinese OEMs.

How will the ADNT–SCI joint venture affect Adient's manufacturing in China?

The JV is aimed at accelerating development and mass production of automotive seating tailored for China OEMs.

What is the ownership percentage Adient took in SCI (Zhangjiakou)?

Adient acquired a 49% equity stake in SCI (Zhangjiakou).

Which customers will the ADNT joint venture primarily target in China?

The joint venture will focus on serving key Chinese OEMs with innovative seating solutions.

What advantages does Adient expect from the joint venture with SCI for stock symbol ADNT?

Adient expects to strengthen its China presence, expand market share, and leverage combined technology and local insights.